Westheim A I, Lookingbill D P
Arch Dermatol. 1987 Jun;123(6):786-9.
We describe a patient with progressive scleromyxedema who failed to respond to previously described treatment modalities. A trial of plasmapheresis was initiated, but after an initial promising response, his disease continued to progress. The skin involvement appeared to progress even more rapidly after the plasmapheresis was discontinued.
